MyAverix Finance MyAverix Finance

STU

Innovent Biologics Inc (6IB)

Innovent Biologics Inc (6IB) is listed on STU. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 6IB

P/E ratio
18.00

Innovent Biologics Inc (6IB) — FAQ

What is 6IB's P/E ratio?

The price-to-earnings (P/E) ratio for Innovent Biologics Inc (6IB) is 18.00 (data as of 2026-05-24).

Does Innovent Biologics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Innovent Biologics Inc (6IB). Check the MyAverix Finance app for the latest dividend data.

What exchange is 6IB listed on?

6IB is listed on STU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play